AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CLINDAMYCINE
8 registrations across 4 African markets— 3 active
Markets with CLINDAMYCINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ENTRACIN 300MG GELULE BOITE DE 100 | 🇨🇮Côte d'Ivoire | ENTRANCE PHARMACEUTICALS & RESEARCH CENTRE | expired | Jan 2021 |
| ENTRACIN 150MG GELULE BOITE DE 100 | 🇨🇮Côte d'Ivoire | ENTRANCE PHARMACEUTICALS & RESEARCH CENTRE | expired | Jan 2021 |
| CLINDAMYCINE KABI Solution injectable / 600 mg/4ml | 🇹🇳Tunisia | FRESENIUS KABI FRANCE | expired | Mar 2017 |
| DALACINE T TOPIC Solution externe / 1% | 🇹🇳Tunisia | PFIZER HOLDING FRANCE | expired | Jul 1990 |
| DALACINE Solution injectable / 600 MG | 🇹🇳Tunisia | PFIZER HOLDING FRANCE | expired | Jun 1989 |
| DALACINE T TOPIC SOLUTION POUR APPLICATION LOCALE | 🇲🇦Morocco | — | active | — |
| CLYCIN – T lotion / 1% | 🇸🇳Senegal | SHAIGAN PHARMACEUTICALS | active | — |
| CLYCIN V crème / 20 mg | 🇸🇳Senegal | SHAIGAN PHARMACEUTICALS | active | — |
CLINDAMYCINE in Africa — Regulatory Overview
CLINDAMYCINE is registered across 4 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Côte d'Ivoire, Senegal, Morocco. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 3 (38%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.